Compare Lustrum:ASKA Pharmaceutical Holdings Co., Ltd.:4886

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ASKA Pharmaceutical Holdings Co., Ltd. Go to web site 4886 Medicals 東証プライム March 1, 2000 2021.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2025年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2024年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2023年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2022年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
10,603down
(10.5%)down
13,738down
(15.1%)down
14,505up
(16.6%)up
12,103up
(14.5%)up
10,514
(12.7%)
Other Current AssetsHelp
(Percent)
47,444up
(47.2%)up
42,405up
(46.7%)up
39,254up
(45.0%)up
37,454up
(45.0%)up
29,418
(35.6%)
Tangible Fixed AssetsHelp
(Percent)
18,709up
(18.6%)up
11,263up
(12.4%)up
10,796down
(12.4%)down
10,936down
(13.1%)down
12,675
(15.3%)
Intangible Fixed AssetHelp
(Percent)
2,632up
(2.6%)up
767down
(0.8%)down
792down
(0.9%)down
817down
(1.0%)down
11,893
(14.4%)
Investments and OthersHelp
(Percent)
16,785down
(16.7%)down
20,462up
(22.5%)up
18,118up
(20.8%)up
16,621up
(20.0%)up
12,716
(15.4%)
Total AssetsHelp
(Percent)
100,534
(100%)
90,745
(100%)
87,138
(100%)
83,297
(100%)
82,582
(100%)
Total Current LiabilitiesHelp
(Percent)
28,783up
(28.6%)up
24,310up
(26.8%)down
23,420up
(26.9%)up
22,082down
(26.5%)down
24,325
(29.5%)
Total Long-term LiabilitiesHelp
(Percent)
6,441up
(6.4%)up
4,505down
(5.0%)down
9,185down
(10.5%)down
12,323down
(14.8%)down
13,747
(16.6%)
Shareholder's EquityHelp
(Percent)
65,310up
(65.0%)down
61,930up
(68.2%)up
54,533up
(62.6%)up
48,892up
(58.7%)up
44,510
(53.9%)
Total LiabilitiesHelp
(Percent)
100,534
(100%)
90,745
(100%)
87,138
(100%)
83,297
(100%)
82,582
(100%)

ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2025年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2024年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2023年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2022年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
64,139
(100%)
62,843
(100%)
60,461
(100%)
56,607
(100%)
55,181
(100%)
Total Sales
(Percent)
64,139
(100%)
62,843
(100%)
60,461
(100%)
56,607
(100%)
55,181
(100%)
Cost of SalesHelp
(Percent)
32,803up
(51.1%)down
32,178up
(51.2%)down
31,876up
(52.7%)down
30,255up
(53.4%)down
29,798
(54.0%)
Other Costs and RevenueHelp 26,235up
(40.9%)up
23,119down
(36.8%)down
24,346up
(40.3%)up
22,062down
(39.0%)down
22,669
(41.1%)
Total CostsHelp 59,038 55,297 56,222 52,317 52,467
Net RevenueHelp 31,336up
(48.9%)up
30,665up
(48.8%)up
28,585up
(47.3%)up
26,352up
(46.6%)up
25,383
(46.0%)
Earnings Before TaxHelp 6,192down
(9.7%)down
9,862up
(15.7%)up
5,357down
(8.9%)down
6,163up
(10.9%)up
3,575
(6.5%)
Net IncomeHelp 5,101down
(8.0%)down
7,546up
(12.0%)up
4,239down
(7.0%)down
4,290up
(7.6%)up
2,714
(4.9%)
当期純利益 5,101 7,546 4,239 4,290 2,714

ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2025年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2024年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2023年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2022年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
3,041up
(33.1%)down
1,486down
(37.5%)down
3,350up
(100.0%)up
2,842down
(29.7%)down
6,540
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-6,124down
(-66.7%)down
1,706up
(43.1%)up
-1,126down
(-33.6%)down
6,743up
(70.3%)up
-2,866
(-43.8%)
Financing Cash FlowHelp
(Percent)
-2,956up
(-32.2%)up
-3,943down
(-99.6%)down
-1,820up
(-54.3%)down
-2,996down
(-31.3%)down
-455
(-7.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-97down
(-1.1%)down
-15down
(-0.4%)down
-2
(-0.1%)
0
-
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn -6,136down
(-66.9%)down
-766down
(-19.4%)down
402down
(12.0%)down
6,589up
(68.7%)up
3,219
(49.2%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ASKA Pharmaceutical Holdings Co., Ltd.

Company where related level is highHelp

Mitsubishi Tanabe Pharma Corporation
K Pharma,Inc.
Carna Biosciences,Inc.
タウンズ
CHUKYOIYAKUHIN CO.,LTD.
StemRIM Inc.
NANO MRNA Co., Ltd.
Heartseed
Cyfuse Biomedical K.K.
Perseus Proteomics Inc.